These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915 [TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138 [TBL] [Abstract][Full Text] [Related]
6. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370 [TBL] [Abstract][Full Text] [Related]
8. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Fine BA; Valente PT; Feinstein GI; Dey T Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma]. Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer. Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer. Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391 [TBL] [Abstract][Full Text] [Related]
14. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances]. Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817 [TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Offersen BV; Pfeiffer P; Andreasen P; Overgaard J Lung Cancer; 2007 Apr; 56(1):43-50. PubMed ID: 17207889 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Hasegawa Y; Takanashi S; Kanehira Y; Tsushima T; Imai T; Okumura K Cancer; 2001 Mar; 91(5):964-71. PubMed ID: 11251948 [TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Shibusa T; Shijubo N; Abe S Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466 [TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730 [TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]